MedPath
NMPA Approval

Loteprednol Etabonate Ophthalmic Suspension

国药准字HJ20160346

November 4, 2024

H20160346

Drug Information

氯替泼诺混悬滴眼液

露达舒

眼用制剂

0.5%(5ml:25mg)

化学药品

November 4, 2024

November 3, 2029

Company Information

Applicant Company

400 Somerset Corporate Blvd, Bridgewater, NJ 08807 USA

Manufacturing Company

8500 Hidden River Parkway, Tampa, Florida 33637, USA

© Copyright 2025. All Rights Reserved by MedPath
氯替泼诺混悬滴眼液 - NMPA 批准文号 | MedPath